- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pfizer Inc (PFE)
Pfizer Inc stock price live, this page displays NYSE PFE stock exchange data. View the PFE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Pfizer Inc real time stock price chart below.
What Is the Pfizer Inc Stock Price Today?
The Pfizer Inc stock price today is 24.26.
What Is the Stock Symbol for Pfizer Inc?
The stock symbol for Pfizer Inc is ""PFE.""
What Stock Exchange Does Pfizer Inc Trade On?
Pfizer Inc is listed and trades on the NYSE stock exchange.
Is Pfizer Inc a Good Stock to Buy?
Determining whether Pfizer Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PFE quote. (ISIN: US7170811035)
What Is the Pfizer Inc Stock Price Today?
The Pfizer Inc stock price today is 24.26.
What Is the Stock Symbol for Pfizer Inc?
The stock symbol for Pfizer Inc is ""PFE.""
What Stock Exchange Does Pfizer Inc Trade On?
Pfizer Inc is listed and trades on the NYSE stock exchange.
Is Pfizer Inc a Good Stock to Buy?
Determining whether Pfizer Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PFE quote. (ISIN: US7170811035)
NYSE
Currency in USD
24.26
-0.21(-0.86%)
Closed·
Pre Market
24.37+0.11(+0.45%)
·
Fair Value
An estimate of a Pfizer's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.26
24.65
52 wk Range
20.92
31.54
PFE Scorecard
Full Analysis
High shareholder yield
Earnings results expected in 14 days
More Info
Fair Value
An estimate of a Pfizer's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
24.2624.65
52 wk Range
20.9231.54
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(7.09%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(7.09%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PFE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Pfizer's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
29.23
Upside
+20.49%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 14 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Pfizer Inc Company Profile
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Pfizer Inc SWOT Analysis
Pipeline Progress | Explore Pfizer's robust oncology pipeline, including promising SSGJ-707 data in NSCLC and the transformative Seagen acquisition, positioning for future growth |
Financial Resilience | Pfizer maintains 2025 revenue guidance of $61-64B, with COVID-19 franchise contributing $9.3B. EPS guidance raised to $2.80-3.00, reflecting operational efficiency |
Strategic Cost Savings | Delve into Pfizer's $1.2B cost realignment program and $4.5B net savings target, driving margin expansion and EPS growth amid market challenges |
Market Dynamics | Analyst targets range from $24 to $36, reflecting varied outlooks on Pfizer's ability to navigate LOEs, regulatory changes, and intense market competition |
Pfizer Inc Earnings Call Summary for Q1/2025
- Pfizer Q1 2025 EPS of $0.92 beat $0.68 forecast; revenue of $13.7B missed expectations; stock rose 3.75% pre-market
- Revenue declined 6% operationally; company returned $2.4B to shareholders via dividends; adjusted gross margin ~81%
- Full-year 2025 guidance: revenue $61-64B, adjusted EPS $2.80-$3.00; trending towards upper end of EPS range
- Focus on growth areas: oncology, vaccines, internal medicine; cost realignment and manufacturing optimization ongoing
- Risks include Medicare Part D redesign, potential tariff impacts, sector competition, and maintaining market leadership
Last Updated: 29/04/2025, 16:46
Read Full TranscriptCompare PFE to Peers and Sector
Metrics to compare | PFE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPFEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 17.5x | −1.2x | −0.5x | |
PEG Ratio | 0.01 | 0.00 | 0.00 | |
Price/Book | 1.5x | 2.9x | 2.6x | |
Price / LTM Sales | 2.2x | 7.2x | 3.2x | |
Upside (Analyst Target) | 15.4% | 155.3% | 44.1% | |
Fair Value Upside | Unlock | 6.4% | 6.2% | Unlock |
Analyst Ratings
9 Buy
15 Hold
1 Sell
Ratings:
25 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 29.23
(+20.49% Upside)
Earnings
Latest Release
Apr 29, 2025
EPS / Forecast
0.92 / 0.68
Revenue / Forecast
13.72B / 14.09B
People Also Watch
FAQ
What Stock Exchange Does Pfizer Trade On?
Pfizer is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Pfizer?
The stock symbol for Pfizer is "PFE."
What Is the Pfizer Market Cap?
As of today, Pfizer market cap is 137.93B.
What Is Pfizer's Earnings Per Share (TTM)?
The Pfizer EPS (TTM) is 1.39.
When Is the Next Pfizer Earnings Date?
Pfizer will release its next earnings report on 04 Aug 2025.
From a Technical Analysis Perspective, Is PFE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Pfizer Stock Split?
Pfizer has split 6 times.
How Many Employees Does Pfizer Have?
Pfizer has 81000 employees.
What is the current trading status of Pfizer (PFE)?
As of 22 Jul 2025, Pfizer (PFE) is trading at a price of 24.26, with a previous close of 24.26. The stock has fluctuated within a day range of 24.26 to 24.65, while its 52-week range spans from 20.92 to 31.54.
What Is Pfizer (PFE) Price Target According to Analysts?
The average 12-month price target for Pfizer is USD29.23, with a high estimate of USD41.49 and a low estimate of USD23. 9 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +20.49% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.